327 related articles for article (PubMed ID: 21956108)
21. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.
Asai M; Hattori C; Szabó B; Sasagawa N; Maruyama K; Tanuma S; Ishiura S
Biochem Biophys Res Commun; 2003 Jan; 301(1):231-5. PubMed ID: 12535668
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.
Woods NK; Padmanabhan J
J Biol Chem; 2013 Oct; 288(42):30114-30124. PubMed ID: 24022491
[TBL] [Abstract][Full Text] [Related]
23. A Bioengineering Strategy to Control ADAM10 Activity in Living Cells.
Pastore F; Battistoni M; Sollazzo R; Renna P; Paciello F; Li Puma DD; Barone E; Dagliyan O; Ripoli C; Grassi C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674432
[TBL] [Abstract][Full Text] [Related]
24. Sox2 functionally interacts with βAPP, the βAPP intracellular domain and ADAM10 at a transcriptional level in human cells.
Sarlak G; Htoo HH; Hernandez JF; Iizasa H; Checler F; Konietzko U; Song W; Vincent B
Neuroscience; 2016 Jan; 312():153-64. PubMed ID: 26592717
[TBL] [Abstract][Full Text] [Related]
25. Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma.
Erin N; İpekçi T; Akkaya B; Özbudak İH; Baykara M
Urol Oncol; 2017 Jan; 35(1):36.e15-36.e22. PubMed ID: 27692848
[TBL] [Abstract][Full Text] [Related]
26. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP
Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
29. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
30. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form.
Mongaret C; Alexandre J; Thomas-Schoemann A; Bermudez E; Chéreau C; Nicco C; Goldwasser F; Weill B; Batteux F; Lemare F
Int J Cancer; 2011 Aug; 129(4):791-8. PubMed ID: 21064090
[TBL] [Abstract][Full Text] [Related]
31. Shedding of klotho by ADAMs in the kidney.
van Loon EP; Pulskens WP; van der Hagen EA; Lavrijsen M; Vervloet MG; van Goor H; Bindels RJ; Hoenderop JG
Am J Physiol Renal Physiol; 2015 Aug; 309(4):F359-68. PubMed ID: 26155844
[TBL] [Abstract][Full Text] [Related]
32. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
33. Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.
Marcello E; Saraceno C; Musardo S; Vara H; de la Fuente AG; Pelucchi S; Di Marino D; Borroni B; Tramontano A; Pérez-Otaño I; Padovani A; Giustetto M; Gardoni F; Di Luca M
J Clin Invest; 2013 Jun; 123(6):2523-38. PubMed ID: 23676497
[TBL] [Abstract][Full Text] [Related]
34. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
35. TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.
Noy PJ; Yang J; Reyat JS; Matthews AL; Charlton AE; Furmston J; Rogers DA; Rainger GE; Tomlinson MG
J Biol Chem; 2016 Feb; 291(7):3145-57. PubMed ID: 26668317
[TBL] [Abstract][Full Text] [Related]
36. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
[TBL] [Abstract][Full Text] [Related]
39. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
40. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
